Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Geographic and clinical predictors of one-day discharge after radical prostatectomy: a SEER-Medicare cohort study

View ORCID ProfileJacob Hanna, View ORCID ProfileMegan R. Shanahan, Jennifer Sykes, Farzin Khosrow-Khavar, Thomas L. Jang, View ORCID ProfileHari S. Iyer
doi: https://doi.org/10.64898/2026.09.16.26363208
Jacob Hanna
1Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob Hanna
Megan R. Shanahan
2Section of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute, New Brunswick, New Jersey, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Megan R. Shanahan
Jennifer Sykes
1Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farzin Khosrow-Khavar
3Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas L. Jang
1Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
2Section of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute, New Brunswick, New Jersey, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hari S. Iyer
1Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States of America
2Section of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute, New Brunswick, New Jersey, United States of America
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Hari S. Iyer
  • For correspondence: hari.iyer{at}rutgers.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To study the geographic patterns, temporal trends, and predictors of one-day discharge following radical prostatectomy.

Methods We conducted a retrospective cohort study of men diagnosed with prostate cancer from 2008 to 2019 in the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database. Patients with metastatic disease, health maintenance organization coverage, or age younger than 66 years were excluded. Type of surgery and length of stay were derived from inpatient claims. We compared one-day discharge by early (2008–2013) and late (2014–2019) periods, by census region, and by individual- and facility-level factors, and used generalized estimating equations to estimate adjusted odds ratios (aOR) with 95% confidence intervals (CI), accounting for clustering of patients within hospitals.

Results Among 40,728 patients treated at 1,048 hospitals, 52.4% were discharged on postoperative day 1, increasing from 48.8% (2008–2013) to 56.8% (2014–2019). Higher odds of one-day discharge were associated with robotic surgery (aOR 2.88, 95% CI 2.54–3.27) and treatment at a National Cancer Institute-designated comprehensive cancer center (aOR 1.88, 95% CI 1.28–2.76). Black versus White patients (aOR 0.76, 95% CI 0.70–0.82), unmarried versus married patients (aOR 0.79, 95% CI 0.73–0.85), and patients in the lowest versus highest neighborhood socioeconomic quintile (aOR 0.86, 95% CI 0.79–0.94) had lower odds. Odds were 31% higher in the late versus early period (aOR 1.31, 95% CI 1.20–1.43). Regional differences were attenuated in sensitivity analyses.

Conclusions One-day discharge after radical prostatectomy has increased over time and is now the predominant practice among Medicare beneficiaries, driven primarily by robotic surgery and treatment era. Persistent racial and socioeconomic differences in discharge patterns warrant further research into whether early discharge is equally safe and beneficial across patient populations.

Competing Interest Statement

The authors have declared no competing interest.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Rutgers University Institutional Review Board, Study ID Pro2021001673. Informed consent was waived because the study analyzed de-identified secondary data (SEER-Medicare linked database) under a National Cancer Institute data use agreement.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

The data underlying this study are third-party data from the SEER-Medicare linked database, obtained from the U.S. National Cancer Institute (NCI) under a data use agreement. The authors are not permitted to share these data publicly because they contain protected health information governed by NCI and the Centers for Medicare & Medicaid Services. Other researchers may request access to identical SEER-Medicare data through the NCI Healthcare Delivery Research Program (https://healthcaredelivery.cancer.gov/seermedicare/obtain/), subject to approval of a data request and execution of a data use agreement. The authors did not have any special access privileges that others would not have. SAS code used for cohort construction and analysis is available from the corresponding author on request.

https://healthcaredelivery.cancer.gov/seermedicare/obtain/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted September 17, 2026.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Geographic and clinical predictors of one-day discharge after radical prostatectomy: a SEER-Medicare cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Geographic and clinical predictors of one-day discharge after radical prostatectomy: a SEER-Medicare cohort study
Jacob Hanna, Megan R. Shanahan, Jennifer Sykes, Farzin Khosrow-Khavar, Thomas L. Jang, Hari S. Iyer
medRxiv 2026.09.16.26363208; doi: https://doi.org/10.64898/2026.09.16.26363208
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Geographic and clinical predictors of one-day discharge after radical prostatectomy: a SEER-Medicare cohort study
Jacob Hanna, Megan R. Shanahan, Jennifer Sykes, Farzin Khosrow-Khavar, Thomas L. Jang, Hari S. Iyer
medRxiv 2026.09.16.26363208; doi: https://doi.org/10.64898/2026.09.16.26363208

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Urology
Subject Areas
All Articles
  • Addiction Medicine (638)
  • Allergy and Immunology (922)
  • Anesthesia (353)
  • Cardiovascular Medicine (5024)
  • Dentistry and Oral Medicine (496)
  • Dermatology (429)
  • Emergency Medicine (680)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1696)
  • Epidemiology (16286)
  • Forensic Medicine (36)
  • Gastroenterology (1243)
  • Genetic and Genomic Medicine (7298)
  • Geriatric Medicine (754)
  • Health Economics (1095)
  • Health Informatics (5307)
  • Health Policy (1476)
  • Health Systems and Quality Improvement (1837)
  • Hematology (599)
  • HIV/AIDS (1383)
  • Infectious Diseases (except HIV/AIDS) (16508)
  • Intensive Care and Critical Care Medicine (1203)
  • Medical Education (701)
  • Medical Ethics (157)
  • Nephrology (754)
  • Neurology (7620)
  • Nursing (380)
  • Nutrition (1133)
  • Obstetrics and Gynecology (1297)
  • Occupational and Environmental Health (1041)
  • Oncology (3752)
  • Ophthalmology (1097)
  • Orthopedics (411)
  • Otolaryngology (468)
  • Pain Medicine (503)
  • Palliative Medicine (143)
  • Pathology (722)
  • Pediatrics (1864)
  • Pharmacology and Therapeutics (758)
  • Primary Care Research (788)
  • Psychiatry and Clinical Psychology (6156)
  • Public and Global Health (10017)
  • Radiology and Imaging (2543)
  • Rehabilitation Medicine and Physical Therapy (1527)
  • Respiratory Medicine (1274)
  • Rheumatology (663)
  • Sexual and Reproductive Health (806)
  • Sports Medicine (599)
  • Surgery (806)
  • Toxicology (109)
  • Transplantation (320)
  • Urology (309)